To meet the needs of this new era, Fujifilm has evolved into a comprehensive healthcare company, offering products in the fields of prevention, diagnostics and treatment.
With its wide range of technologies and expansive vision, Fujifilm leverages the products, services, and hard-earned expertise that is rooted in the development of photographic products to enhance the quality of life of people worldwide. The schematic below shows our extraordinary progress so far and points towards emerging innovations ahead.
Cell Culture Media
Cell Therapy Development
Investigational Drug Development
Life Sciences Strategy
Launched X-ray film
Launched first endoscope system
Launched world's first digital radiography system: FCR
Launched first commercially available flexible video endoscope
Acquired Pyne Corp., – becoming FUJIFILM Medical Systems U.S.A., Inc.
Launched Synapse® Picture Archiving and Communications System (PACS)
Launched endoscope for the full length of small bowel
Acquired Daiichi Radioisotope Laboratories – becoming FUJIFILM Toyama Chemical
Acquired ProSolv, a cardiology PACS vendor
Launched Synapse® 3D
Acquired Toyoma Chemical – becoming FUJIFILM Toyoma Chemical